‘Last man standing’: How will NHS strike action affect community pharmacy?

Amid widespread disputes over NHS pay and conditions and a vote by nurses to take strike action, C+D has asked pharmacy bodies for their view on how community pharmacy teams and demand for services could be affected

RCN strikes pharmacy
The RCN’s mandate to organise strikes remains in place until early May 2023

Members of the Royal College of Nursing (RCN) union are set to stage their first national strike across all four UK nations – for the first time in the body's 106-year history – after a ballot saw most NHS Trusts in England reach the 50% turnout threshold needed for strike action.

Free to registered users

Register to gain full access to C+D and C+D Community content

Sign in or register for free

Latest from Analysis

Why I’ve launched a campaign against the RPS’s planned changes

 
• By 
 • comment

‘Vote no’ campaigner Martin Astbury tells C+D why he believes the RPS plans for change represent a shift away from pharmacist leadership and why members should vote against them this week…

CPE is negotiating in a very difficult and nuanced environment that few will have experienced

 
• By 
 • comment

I also read comments that CPE does not appreciate this critical position, and I fundamentally refute that. Knowing the colleagues, both elected and employed, at CPE as I do, this is far from the case.

It’s not just funding delays holding pharmacy back, it’s the old dinosaurs too...

 
• By 
 • comment

Community pharmacy is risk adverse, considered, and dare I say it, conservative. But, when it comes to the survival of pharmacy, we can’t afford to let the fear of change – or those resistant to it - hold us back.

More from Business

breaking news

IN FULL: Boots’ parent company sold in $24bn private equity deal

 
• By 
 • comment8

Walgreens Boots Alliance (WBA) has “entered into a definitive agreement to be acquired” by private equity firm Sycamore Partners.

Jhoots accounts: Shareholder funds tumble while debts soar

 
• By 
 • comment2

Jhoots Chemist’s accounts for 2024 have revealed an almost £2 million year-on-year dip in shareholder funds – as debts to creditors increase more than £2m.